Literature DB >> 21916806

Characterization of circulating HIV type 1 env genes in plasma of two antiretroviral-naive slow progressing patients with broad neutralizing antibody response with evidence of recombination.

Sampurna Mukhopadhyay1, Rajesh Ringe, Ajit Patil, Ramesh Paranjape, Jayanta Bhattacharya.   

Abstract

In the present study, we investigated genetic divergence between complete autologous HIV-1 env genes amplified directly from plasma of two antiretroviral-naive, slow progressing Indian patients with broad neutralizing antibody response. All the envelope (Env) clones obtained from one patient (LT1) belonged to subtype C; the second patient (LT5) harbored quasispecies comprised of pure B, C, and B/C recombinants with distinct breakpoints indicative of dual infection with genetically distinct strains. Further characterization of these Envs would provide insight into the biological properties under strong humoral immune response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21916806      PMCID: PMC3380387          DOI: 10.1089/AID.2011.0238

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  33 in total

Review 1.  HIV-1 sequence variation: drift, shift, and attenuation.

Authors:  M H Malim; M Emerman
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection.

Authors:  Bin Wang; Meriet Mikhail; Wayne B Dyer; John J Zaunders; Anthony D Kelleher; Nitin K Saksena
Journal:  Virology       Date:  2003-07-20       Impact factor: 3.616

3.  Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.

Authors:  B Asjö; L Morfeldt-Månson; J Albert; G Biberfeld; A Karlsson; K Lidman; E M Fenyö
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

4.  HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions.

Authors:  M Goodenow; T Huet; W Saurin; S Kwok; J Sninsky; S Wain-Hobson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

5.  Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.

Authors:  M Tersmette; R A Gruters; F de Wolf; R E de Goede; J M Lange; P T Schellekens; J Goudsmit; H G Huisman; F Miedema
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Recombination following superinfection by HIV-1.

Authors:  Guowei Fang; Barbara Weiser; Carla Kuiken; Sean M Philpott; Sarah Rowland-Jones; Francis Plummer; Joshua Kimani; Binshan Shi; Rupert Kaul; Job Bwayo; Omu Anzala; Harold Burger
Journal:  AIDS       Date:  2004-01-23       Impact factor: 4.177

7.  Biologic features of HIV-1 that correlate with virulence in the host.

Authors:  C Cheng-Mayer; D Seto; M Tateno; J A Levy
Journal:  Science       Date:  1988-04-01       Impact factor: 47.728

8.  Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection.

Authors:  Bin Wang; Wayne B Dyer; John J Zaunders; Meriet Mikhail; John S Sullivan; Lisa Williams; Da'ed N Haddad; Graeme Harris; John A G Holt; David A Cooper; Monica Miranda-Saksena; Ross Boadle; Anthony D Kelleher; Nitin K Saksena
Journal:  Virology       Date:  2002-12-20       Impact factor: 3.616

9.  Dual HIV-1 infection associated with rapid disease progression.

Authors:  Geoffrey S Gottlieb; David C Nickle; Mark A Jensen; Kim G Wong; Jandre Grobler; Fusheng Li; Shan-Lu Liu; Cecilia Rademeyer; Gerald H Learn; Salim S Abdool Karim; Carolyn Williamson; Lawrence Corey; Joseph B Margolick; James I Mullins
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

10.  Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection.

Authors:  Rajesh Ringe; Madhuri Thakar; Jayanta Bhattacharya
Journal:  Retrovirology       Date:  2010-09-22       Impact factor: 4.602

View more
  4 in total

1.  Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificities.

Authors:  Ranajoy Mullick; Jyoti Sutar; Nitin Hingankar; Suprit Deshpande; Madhuri Thakar; Seema Sahay; Rajesh P Ringe; Sampurna Mukhopadhyay; Ajit Patil; Shubhangi Bichare; Kailapuri G Murugavel; Aylur K Srikrishnan; Rajat Goyal; Devin Sok; Jayanta Bhattacharya
Journal:  Retrovirology       Date:  2021-05-14       Impact factor: 4.602

2.  Unique C2V3 sequence in HIV-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization.

Authors:  Rajesh Ringe; Lipsa Das; Ipsita Choudhary; Deepak Sharma; Ramesh Paranjape; Virander Singh Chauhan; Jayanta Bhattacharya
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

3.  The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards.

Authors:  Sung Yong Park; Tanzy M T Love; Lucy Reynell; Carl Yu; Tina Manzhu Kang; Kathryn Anastos; Jack DeHovitz; Chenglong Liu; Kord M Kober; Mardge Cohen; Wendy J Mack; Ha Youn Lee
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

4.  Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes.

Authors:  Rajesh Kumar; Gabriel Ozorowski; Vivek Kumar; Lauren G Holden; Tripti Shrivastava; Shilpa Patil; Suprit Deshpande; Andrew B Ward; Jayanta Bhattacharya
Journal:  J Biol Chem       Date:  2017-07-25       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.